Major efforts continue to protect the beleaguered discount drug program.
The American Hospital Association (AHA) filed a supporting brief to the US Court of Appeals in the third appellate district. SANOFI-AVENTIS U.S. LLC, Plaintiff-Appellant/Cross-Appellee, v. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, et al.
Summarizing the case, the pharmaceutical companies in 2020, as the COVID-19 pandemic roared, began refusing to give discounts on drugs purchased and distributed by 340B covered entities using contract pharmacies. The drug companies began refusing to honor 340B discounts unless the drugs were both purchased and dispensed by the covered entity.
Most 340B recipients do not operate their own in-house pharmacy. It is my opinion, and that of the AHA it appears, that there is no language in the 340B regulations requiring that only pharmacies operated by the 340B provider be allowed to benefit from 340B drug pricing.
Due to the complexity of running a pharmacy, it is out of the budget for most 340B recipients to create an in-house pharmacy. It also ignores the economies of scale that using contract pharmacies provide. Maybe as importantly, such in-house pharmacies would no be able to offer patients the benefits of technologies that scale.
In my opinion, this is part of an ongoing push by drug companies into the healthcare market, particularly the rural market. Drug companies have an inherent conflict of interest when they are both 340B drug providers and healthcare providers in the same markets.
Few folks think of the Stark laws that restrict self-dealing among physicians and what is going on in the pharmaceutical industry. Maybe it is time to revisit Stark and add other providers including drug companies into Stark restrictions.
The Biden Administration has been extremely busy this summer, with the development of new initiatives designed to reform the healthcare system in the U.S. The
The Children’s Health Insurance Program (CHIP) was created as part of the Balanced Budget Act of 1997 (BBA 97) to provide health insurance to children
Please log in to your account to comment on this article.
Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY26 IPPS, including new ICD-10-CM/PCS codes, CCs/MCCs, and MS-DRGs, plus insights, analysis and answers to your questions from two of the country’s most respected subject matter experts.
This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.
This second session in our 2026 IPPS Masterclass will feature a review the FY26 changes to ICD-10-PCS codes. This information will be presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.
This first session in our 2026 IPPS Masterclass will feature an in-depth explanation of FY26 changes to ICD-10-CM codes and guidelines, CCs/MCCs, and revisions to the MCE, presented by presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.
RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.
Bring your questions and join the conversation during this open forum series, live every Wednesday at 10 a.m. EST from June 11–July 30. Hosted by Chuck Buck, these fast-paced 30-minute sessions connect you directly with top healthcare experts tackling today’s most urgent compliance and policy issues.
Fraud convictions don’t just punish a few bad claims; they can wipe out years of reimbursements. Don’t wait for an audit to learn the rules. Join Frank Cohen, MPA, for a live Q&A on spotting red flags, avoiding liability, and protecting your practice. Register now and bring your questions!
Substance abuse is everywhere. It’s a complicated diagnosis with wide-ranging implications well beyond acute care. The face of addiction continues to change so it’s important to remember not just the addict but the spectrum of extended victims and the other social determinants and legal ramifications. Join John K. Hall, MD, JD, MBA, FCLM, FRCPC, for a critical Q&A on navigating substance abuse in 2025. Register today and be a part of the conversation!
Copyright © 2025 ICD10monitor. Powered by MedLearn Media.
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
